PRIMARY CARBOXAMIDES AS BTK INHIBITORS

The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.

Saved in:
Bibliographic Details
Main Authors Frank, Kristine E, Osuma, Augustine, Van Epps, Stacy A, Wang, Zhi, Bonafoux, Dominique, Huntley, Raymond, Sheppard, George, Van Camp, Jennifer, Davis, Heather M, Xu, Xiangdong, Friedman, Michael M, Wallace, Grier A, Vasudevan, Anil, Somal, Gagandeep K, Hoemann, Michael Z, Wilson, Noel S, Wang, Lu, Herold, J. Martin
Format Patent
LanguageCroatian
English
Published 22.02.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

Abstract The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
AbstractList The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Author Osuma, Augustine
Sheppard, George
Herold, J. Martin
Frank, Kristine E
Vasudevan, Anil
Wang, Zhi
Huntley, Raymond
Davis, Heather M
Van Epps, Stacy A
Somal, Gagandeep K
Wilson, Noel S
Bonafoux, Dominique
Wallace, Grier A
Wang, Lu
Xu, Xiangdong
Friedman, Michael M
Hoemann, Michael Z
Van Camp, Jennifer
Author_xml – fullname: Frank, Kristine E
– fullname: Osuma, Augustine
– fullname: Van Epps, Stacy A
– fullname: Wang, Zhi
– fullname: Bonafoux, Dominique
– fullname: Huntley, Raymond
– fullname: Sheppard, George
– fullname: Van Camp, Jennifer
– fullname: Davis, Heather M
– fullname: Xu, Xiangdong
– fullname: Friedman, Michael M
– fullname: Wallace, Grier A
– fullname: Vasudevan, Anil
– fullname: Somal, Gagandeep K
– fullname: Hoemann, Michael Z
– fullname: Wilson, Noel S
– fullname: Wang, Lu
– fullname: Herold, J. Martin
BookMark eNrjYmDJy89L5WRQCwjy9HUMilRwdgxy8o9w9PV0cQ1WcAxWcArxVvD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxHkEBRgaGlgYGlsYhIYbGxKkCAE8kJsc
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate PRIMARNI KARBOKSAMIDI KAO INHIBITORI BTK
ExternalDocumentID HRP20190093TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP20190093TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:40:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Croatian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP20190093TT13
Notes Application Number: HR2019P000093T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190222&DB=EPODOC&CC=HR&NR=P20190093T1
ParticipantIDs epo_espacenet_HRP20190093TT1
PublicationCentury 2000
PublicationDate 20190222
PublicationDateYYYYMMDD 2019-02-22
PublicationDate_xml – month: 02
  year: 2019
  text: 20190222
  day: 22
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies Abbvie Inc
RelatedCompanies_xml – name: Abbvie Inc
Score 3.1854498
Snippet The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title PRIMARY CARBOXAMIDES AS BTK INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190222&DB=EPODOC&locale=&CC=HR&NR=P20190093T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlILStyLtsl4eivRKq_RCWqU-jfXGRNCxVfz7noTO-bS3JAdyg5MvX5LvBODeaBSi1poqGZXeSkSpZanUmBBYY6FT6hYxhQmFo1gNXshTMS0G8LHRwvA4oT88OCJ6VIX-3vH1erk9xHL528r1Q_mORV-Pfm66Ys-OEd0Q70TXNr00cRNHdBwzoGJMzZQbkb7nSJX22D6aBdr3Xm0mS1n-xxT_GPZTrO6zO4HBYjWCQ2fz9doIDqL-xhuTvfOtT0FMaRhZ9E1wLGonhRWFrpcJVibY-bMQxkFoh3lCszO4873cCSRscPY3vFlAt53L5ck5DJH4NxcgaJVMWlJXRJvLhElojOlcL7V6rjZlpSuTSxjvqulqt_kajliOy7OVMQy71XdzgwDblbd8Yn4B41Z6gQ
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqXqQWlb0XaZc32UKS30br1QhplPo31MhRBx1bx73sSNufT3kIOnFzg5MtJ8n0BuB9UBjFLamqDoj_XiFHqWk4FEZgK6ZRyjpgiiMJRbAbP5GnSmzTgY8OFkTqhP1IcESOqwHiv5Xq92B5iefJt5eohf8eqr8chtzx1nR0juiHeqZ5j-WniJa7qulbA1JhZqTRi-s4xVdqjQp5X7J1eHEFLWfzHlOER7Kfo7rM-hsbbsg0td_P1WhsOovWNNxbXwbc6ATVlYWSzV8W1mZNM7Cj0_EyxM8XhIyWMg9AJecKyU7gb-twNNGxw-je8acC2neN69wyamPhX56DQQidzUhaEznQiKDSD3qyf03JmVnnRN7oX0Nnl6XK3-RZaAY_G03EYj67gUFgkVdvoQLNeflfXCLZ1fiMn6RfGBH1u
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PRIMARY+CARBOXAMIDES+AS+BTK+INHIBITORS&rft.inventor=Frank%2C+Kristine+E&rft.inventor=Osuma%2C+Augustine&rft.inventor=Van+Epps%2C+Stacy+A&rft.inventor=Wang%2C+Zhi&rft.inventor=Bonafoux%2C+Dominique&rft.inventor=Huntley%2C+Raymond&rft.inventor=Sheppard%2C+George&rft.inventor=Van+Camp%2C+Jennifer&rft.inventor=Davis%2C+Heather+M&rft.inventor=Xu%2C+Xiangdong&rft.inventor=Friedman%2C+Michael+M&rft.inventor=Wallace%2C+Grier+A&rft.inventor=Vasudevan%2C+Anil&rft.inventor=Somal%2C+Gagandeep+K&rft.inventor=Hoemann%2C+Michael+Z&rft.inventor=Wilson%2C+Noel+S&rft.inventor=Wang%2C+Lu&rft.inventor=Herold%2C+J.+Martin&rft.date=2019-02-22&rft.externalDBID=T1&rft.externalDocID=HRP20190093TT1